XCL2 and glioblastoma: We calculated the stromal, immune, and ESTIMATE scores and tumor purity of 33 cancers using Spearman’s correlation analysis and found that immune scores were positively associated with XCL2 expression, especially in BRCA, GBM, KIRC, and THCA (Figure 5A–5D).